Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical implication of cellular vaccine in glioma: current advances and future prospects
Yuanliang Yan, Shuangshuang Zeng, Zhicheng Gong, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme
Asraa Faris Aldoghachi, Ahmed Faris Aldoghachi, Koen Breyne, et al.
Neuroscience (2022) Vol. 491, pp. 240-270
Closed Access | Times Cited: 66
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Berta Segura‐Collar, Sara Hiller-Vallina, Olaya de Dios, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 12
Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma
Ruth M. Urbantat, Peter Vajkoczy, Susan Brandenburg
Cancers (2021) Vol. 13, Iss. 12, pp. 2983-2983
Open Access | Times Cited: 48
Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses
Jinwu Peng, Qiuju Liang, Zhijie Xu, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 29
Dendritic cell vaccines for glioblastoma fail to complete clinical translation: Bottlenecks and potential countermeasures
Luohong Li, Jing Zhou, Xueting Dong, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108929-108929
Closed Access | Times Cited: 22
Natural Products for the Immunotherapy of Glioma
Qi Huang, Xier Pan, Wenhao Zhu, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2795-2795
Open Access | Times Cited: 15
Current Status and Challenges of Vaccination Therapy for Glioblastoma
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds
Sweety Asija, Abhishek Chatterjee, Sandhya Yadav, et al.
International Reviews of Immunology (2022) Vol. 41, Iss. 6, pp. 582-605
Closed Access | Times Cited: 21
Investigation of the Impact of Magnetic Resonance Imaging-assisted Surgery on Immune Cell Cytokine Levels and Efficacy in Patients with Gliomas
Xueshan Qian, Li Yang, Yonghui Shi
Current Problems in Surgery (2024) Vol. 63, pp. 101640-101640
Closed Access | Times Cited: 4
Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases
Puja Sandhbor, Geofrey John, Sakshi Bhat, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101021-101021
Open Access
Current immunotherapeutic approaches to diffuse intrinsic pontine glioma
Catherine Lin, Christian A. Smith, James T. Rutka
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 3
Targeted therapies for Glioblastoma multiforme (GBM): State‐of‐the‐art and future prospects
S. Satish, Maithili Athavale, Prashant S. Kharkar
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 3
Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
Saadia Ait Ssi, Dounia Chraa, Khadija El Azhary, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises
Faraz Ahmad, Ressin Varghese, Subhrajita Panda, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5389-5389
Open Access | Times Cited: 14
Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis
Elnaz Amanzadeh Jajin, Saeed Oraee‐Yazdani, Alireza Zali, et al.
Oncology Reviews (2024) Vol. 18
Open Access | Times Cited: 2
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2
Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)
Alice Giotta Lucifero, Sabino Luzzi
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 386-386
Open Access | Times Cited: 16
Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
Liying Song, Jiali Wu, Hua Fu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
Bi Peng, Yuanliang Yan, Zhijie Xu
PeerJ (2021) Vol. 9, pp. e12123-e12123
Open Access | Times Cited: 15
The implication of pyroptosis in cancer immunology: Current advances and prospects
Wei Liu, Jinwu Peng, Muzhang Xiao, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2339-2350
Open Access | Times Cited: 10
Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
Mark A. Exley, Samantha Garcia, Amelia Zellander, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1069-1069
Open Access | Times Cited: 9
Prevalence and risk factors of early postoperative seizures in patients with glioma: a systematic review and meta-analysis
Bo Sun, Yuchen Sun, Zijian Wang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top